http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1

description: A pharmaceutical product described in terms of its composition and dose form.
derivation: specialization
name: MedicinalProductPharmaceutical
type: MedicinalProductPharmaceutical
elements:
  identifier: {short: An identifier for the pharmaceutical medicinal product, array: true, isSummary: true, index: 0}
  administrableDoseForm: {short: 'The administrable dose form, after necessary reconstitution', isSummary: true, index: 1}
  unitOfPresentation: {short: Todo, isSummary: true, index: 2}
  ingredient: {short: Ingredient, array: true, isSummary: true, index: 3}
  device: {short: Accompanying device, array: true, isSummary: true, index: 4}
  characteristics:
    short: Characteristics e.g. a products onset of action
    array: true
    isSummary: true
    index: 5
    elements:
      code: {short: A coded characteristic, isSummary: true, index: 6}
      status: {short: The status of characteristic e.g. assigned or pending, isSummary: true, index: 7}
    required: [code]
  routeOfAdministration:
    min: 1
    short: The path by which the pharmaceutical product is taken into or makes contact with the body
    array: true
    isSummary: true
    index: 8
    elements:
      code: {short: Coded expression for the route, isSummary: true, index: 9}
      firstDose: {short: 'The first dose (dose quantity) administered in humans can be specified, for a product under investigation, using a numerical value and its unit of measurement', isSummary: true, index: 10}
      maxSingleDose: {short: The maximum single dose that can be administered as per the protocol of a clinical trial can be specified using a numerical value and its unit of measurement, isSummary: true, index: 11}
      maxDosePerDay: {short: The maximum dose per day (maximum dose quantity to be administered in any one 24-h period) that can be administered as per the protocol referenced in the clinical trial authorisation, isSummary: true, index: 12}
      maxDosePerTreatmentPeriod: {short: The maximum dose per treatment period that can be administered as per the protocol referenced in the clinical trial authorisation, isSummary: true, index: 13}
      maxTreatmentPeriod: {short: The maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation, isSummary: true, index: 14}
      targetSpecies:
        short: A species for which this route applies
        array: true
        isSummary: true
        index: 15
        elements:
          code: {short: Coded expression for the species, isSummary: true, index: 16}
          withdrawalPeriod:
            short: A species specific time during which consumption of animal product is not appropriate
            array: true
            isSummary: true
            index: 17
            elements:
              tissue: {short: 'Coded expression for the type of tissue for which the withdrawal period applues, e.g. meat, milk', isSummary: true, index: 18}
              value: {short: A value for the time, isSummary: true, index: 19}
              supportingInformation: {short: Extra information about the withdrawal period, isSummary: true, index: 20}
            required: [value, tissue]
        required: [code]
    required: [code]
class: resource
kind: resource
url: http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical
base: http://hl7.org/fhir/StructureDefinition/DomainResource
version: 4.0.1
required: [routeOfAdministration, administrableDoseForm]